From: deputydog23x@gmail.com   
      
   The Grapevine   
      
   Cannabis Drug Shows Promise In Treating Schizophrenia   
      
      
   Sep 15, 2015 02:22 PM   
   By Reuters   
    Cannabis   
      
   Marijuana plants grow on the grounds of the Bob Marley Museum in Kingston,   
   Jamaica, June 9, 2015. Robyn Beck/AFP/Getty Images   
      
   (Reuters) - An experimental cannabis drug for treating schizophrenia,   
   developed by UK-based GW Pharmaceuticals Plc, was found to be superior to a   
   placebo in a mid-stage trial.   
      
   The company's UK-listed shares jumped 12.5 percent, while U.S.-listed shares   
   were up 10 pct.   
      
   The drug, cannabidiol, was tested in 88 patients with schizophrenia, who had   
   failed to respond to anti-psychotic medication.   
      
      
   During the trial, patients remained on their anti-psychotic medication and   
   received doses of either cannabidiol or a placebo, the company said in a   
   statement   
      
   GW is testing its cannabis drugs for a number of indications, including   
   cancer-related pain and epilepsy.   
      
   Marijuana, which is the dried bud of the cannabis plant, is illegal under U.S.   
   federal law but is allowed for medical use in about half the country's states.   
      
      
   Interest in the medical effects of cannabis has been spurred recently by the   
   legalization of recreational marijuana shops in Colorado and Canada's move to   
   create a federally regulated medical marijuana industry.   
      
   (Reporting by Amrutha Penumudi in Bengaluru; Editing by Anil D'Silva)   
      
      
   http://www.medicaldaily.com/cannabis-drug-shows-promise-treating   
   schizophrenia-352622   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)